Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles.

Operti MC, Dölen Y, Keulen J, van Dinther EAW, Figdor CG, Tagit O.

Pharmaceutics. 2019 Nov 8;11(11). pii: E590. doi: 10.3390/pharmaceutics11110590.

PMID:
31717354
2.

An efficient synthesis of a 6″-BODIPY-α-Galactosylceramide probe for monitoring α-Galactosylceramide uptake by cells.

Cheng JMH, Chee SH, Dölen Y, Verdoes M, Timmer MSM, Stocker BL.

Carbohydr Res. 2019 Dec 1;486:107840. doi: 10.1016/j.carres.2019.107840. Epub 2019 Oct 18.

PMID:
31689579
3.

Functional diversification of hybridoma-produced antibodies by CRISPR/HDR genomic engineering.

van der Schoot JMS, Fennemann FL, Valente M, Dolen Y, Hagemans IM, Becker AMD, Le Gall CM, van Dalen D, Cevirgel A, van Bruggen JAC, Engelfriet M, Caval T, Bentlage AEH, Fransen MF, Nederend M, Leusen JHW, Heck AJR, Vidarsson G, Figdor CG, Verdoes M, Scheeren FA.

Sci Adv. 2019 Aug 28;5(8):eaaw1822. doi: 10.1126/sciadv.aaw1822. eCollection 2019 Aug.

4.

Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery.

Weiden J, Voerman D, Dölen Y, Das RK, van Duffelen A, Hammink R, Eggermont LJ, Rowan AE, Tel J, Figdor CG.

Front Immunol. 2018 Nov 28;9:2798. doi: 10.3389/fimmu.2018.02798. eCollection 2018.

5.

Endolysosomal-Escape Nanovaccines through Adjuvant-Induced Tumor Antigen Assembly for Enhanced Effector CD8+ T Cell Activation.

Qiu L, Valente M, Dolen Y, Jäger E, Beest MT, Zheng L, Figdor CG, Verdoes M.

Small. 2018 Apr;14(15):e1703539. doi: 10.1002/smll.201703539. Epub 2018 Mar 1.

PMID:
29493121
6.

Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses.

Dölen Y, Kreutz M, Gileadi U, Tel J, Vasaturo A, van Dinther EA, van Hout-Kuijer MA, Cerundolo V, Figdor CG.

Oncoimmunology. 2015 Aug 12;5(1):e1068493. eCollection 2016.

7.

Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists.

Kreutz M, Bakdash G, Dolen Y, Sköld AE, van Hout-Kuijer MA, de Vries IJ, Figdor CG.

Eur J Immunol. 2015 Oct;45(10):2798-809. doi: 10.1002/eji.201545583. Epub 2015 Sep 2.

8.

Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma.

Dolen Y, Gunaydin G, Esendagli G, Guc D.

Cell Immunol. 2015 May;295(1):29-35. doi: 10.1016/j.cellimm.2015.02.005. Epub 2015 Feb 18.

PMID:
25732602
9.

Fibroblast-derived CCL2 induces cancer stem cells--letter.

Gunaydin G, Dolen Y, Kesikli SA.

Cancer Res. 2013 Jan 15;73(2):1031. doi: 10.1158/0008-5472.CAN-12-2379. Epub 2013 Jan 10. No abstract available.

10.

Myeloid leukemia cells with a B7-2(+) subpopulation provoke Th-cell responses and become immuno-suppressive through the modulation of B7 ligands.

Dolen Y, Esendagli G.

Eur J Immunol. 2013 Mar;43(3):747-57. doi: 10.1002/eji.201242814. Epub 2013 Jan 31.

11.

Designing excited states: theory-guided access to efficient photosensitizers for photodynamic action.

Cakmak Y, Kolemen S, Duman S, Dede Y, Dolen Y, Kilic B, Kostereli Z, Yildirim LT, Dogan AL, Guc D, Akkaya EU.

Angew Chem Int Ed Engl. 2011 Dec 9;50(50):11937-41. doi: 10.1002/anie.201105736. Epub 2011 Oct 19. No abstract available.

PMID:
22012892
12.

Endothelial nitric oxide synthase gene polymorphism in gastric cancer.

Tecder Ünal M, Karabulut HG, Gümüş-Akay G, Dölen Y, Elhan A, Tükün A, Ünal AE.

Turk J Gastroenterol. 2010 Dec;21(4):338-44.

13.

CD40 -1C>T single nucleotide polymorphism and CD40 expression on breast tumors.

Dolen Y, Yilmaz G, Esendagli G, Guler NE, Guc D.

Cytokine. 2010 Jun;50(3):243-4. doi: 10.1016/j.cyto.2010.03.010. Epub 2010 Apr 3. No abstract available.

PMID:
20371189
14.

Residents performance in transobturator tape procedures for stress urinary incontinence.

Sivaslioglu AA, Demir B, Dolen Y, Gelisen O, Haberal A.

Eur J Obstet Gynecol Reprod Biol. 2007 Oct;134(2):259-61. Epub 2007 Jan 26.

PMID:
17258381

Supplemental Content

Support Center